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Abstract
Background:  In preparation of vaccines trials to estimate protection against shigellosis and
cholera we conducted a two-year community-based surveillance study in an impoverished area of
North Jakarta which provided updated information on the disease burden in the area.
Methods: We conducted a two-year community-based surveillance study from August 2001 to
July 2003 in an impoverished area of North Jakarta to assess the burden of diarrhoea, shigellosis,
and cholera. At participating health care providers, a case report form was completed and stool
sample collected from cases presenting with diarrhoea.
Results: Infants had the highest incidences of diarrhoea (759/1 000/year) and cholera (4/1 000/
year). Diarrhea incidence was significantly higher in boys under 5 years (387/1 000/year) than girls
under 5 years (309/1 000/year; p < 0.001). Children aged 1 to 2 years had the highest incidence of
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shigellosis (32/1 000/year). Shigella flexneri was the most common Shigella species isolated and 73%
to 95% of these isolates were resistant to ampicillin, trimethoprim-sulfamethoxazole,
chloramphenicol and tetracycline but remain susceptible to nalidixic acid, ciprofloxacin, and
ceftriaxone. We found an overall incidence of cholera of 0.5/1 000/year. Cholera was most
common in children, with the highest incidence at 4/1 000/year in those less than 1 year of age. Of
the 154 V. cholerae O1 isolates, 89 (58%) were of the El Tor Ogawa serotype and 65 (42%) were
El Tor Inaba. Thirty-four percent of patients with cholera were intravenously rehydrated and 22%
required hospitalization. V. parahaemolyticus infections were detected sporadically but increased
from July 2002 onwards.
Conclusion:  Diarrhoea causes a heavy public health burden in Jakarta particularly in young
children. The impact of shigellosis is exacerbated by the threat of antimicrobial resistance, whereas
that of cholera is aggravated by its severe manifestations.
Introduction
Diarrhoeal diseases remain a major cause of morbidity
and mortality in all age groups in impoverished areas of
South East Asia [1-5]. In Indonesia, diarrhoea is the third
leading cause of overall morbidity and the leading cause
of infant mortality [6,7]. Earlier studies extensively
explored the causative organisms of diarrhoea in the
slums of Indonesia's capital, Jakarta [8-11]. In a study con-
ducted from 1997 to 1999, Shigella flexneri was found to
be the most frequently isolated organism from diarrhoea
patients in a community setting in Jakarta [9]. Similarly,
S. flexneri was the most common organism isolated in
eight hospitals throughout the Indonesian archipelago
between 1999 and 2000 [10]. Cholera is another persist-
ent problem in Indonesia. In studies of diarrhoeal out-
breaks throughout Indonesia from 1993 to 1999, Vibrio
cholerae O1 was isolated from 8% to 11% of stool samples
collected [8,12,13].
To plan trials for the evaluation of vaccine candidates it is
essential to understand the disease incidence in the study
area. In preparation of vaccines trials to estimate protec-
tion against shigellosis and cholera we conducted a two-
year community-based surveillance study in an impover-
ished area of North Jakarta. The experience gained during
the surveillance will be useful for future vaccine trials as
well as for the understanding of endemic disease rates in
urban slums in the region.
Methods
Study area and population
North Jakarta, one of five municipal administrative areas
of the city, is 154 km2, had a population of 1 435 207 in
2000, and an estimated population density of 9 314 indi-
viduals/square kilometre. The average annual income per
person in this congested urban site was US$ 689. – in
2000 [14]. Water supply and sanitation are inadequate.
Many homes are temporary structures without running
water and more than a third of households have no access
to tap water. Two adjacent districts (kecamatans) in North
Jakarta, Tanjung Priok and Koja, were selected for the
study based on expected high incidence of the target dis-
eases, accessibility and previous research experience in the
area [15,16]. Residents of the socio-economically better-
off areas of the study site did not participate in the study
due to their known preference for private health care. The
total population enumerated by a study census in 2001
was 160 261 individuals of whom 15 741 (10%) were less
than 60 months of age [17]. The local climate has 2 dis-
tinctive seasons: a rainy season (December–April) and a
dry season (May–November)[18].
Health care system
In the Indonesian public sector, the first-level health care
facility is the public health centre, locally known as the
puskesmas. North Jakarta has 54 public health centres, 22
of which are located in Tanjung Priok and Koja. More
severe conditions are referred to government hospitals.
The Infectious Disease Hospital and Koja Hospital are the
main government referral hospitals in North Jakarta. In
2001, there were 314 private practitioners, 36 polyclinics,
32 maternal clinics, and 29 mostly very small private hos-
pitals in the study area.
Study surveillance procedures
The surveillance was conducted from August 2001 to July
2003. The study was designed to detect all patients resid-
ing in the two study districts presenting with diarrhoea at
participating health care providers: public health centres
in the study area, the Infectious Disease Hospital, and
Koja Hospital. A 2001 survey in the study area asked 8 074
households that had diarrhoea cases in the preceding four
weeks where care was sought [17], and 39% reported they
would use a treatment provider taking part in the surveil-
lance. Based on these findings, we estimate that 61% of
diarrhoea episodes were not captured by our surveillance
system.
In the present study, we invited consenting patients resid-
ing in the study area of all age groups presenting to aBMC Infectious Diseases 2005, 5:89 http://www.biomedcentral.com/1471-2334/5/89
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participating health care provider with loose bowel move-
ment to join the study. Diarrhoea was defined as passage
of three or more loose stools in 24 hours or one or more
loose stool with visible blood. A new diarrhoea episode
was defined if the diarrhoea definition was met after three
of more days free of diarrhoea or dysentery. Shigellosis
was defined as diarrhoea with isolation of Shigella species
from a stool sample. Cholera was defined as diarrhoea
with isolation of V. cholerae O1 or O139 from a stool sam-
ple. Fever was defined as axillary temperature of 37.5°C or
higher.
Study personnel were trained in study procedures. For
every patient presenting with diarrhoea agreeing to take
part in the study, a case report form was completed
describing address, demographics, medical history, phys-
ical examination results, and the treatment plan including
the prescription of antibiotics. Patients who did not con-
sent or had no diarrhea were excluded. Three rectal swabs
were obtained from all study participants. Treatment was
provided to patients in accordance with national guide-
lines and the treatment plan including hospital referral
was recorded. The study did not include follow-up visits
of patients.
For isolation of Shigella  species, one rectal swab was
placed in buffered glycerol saline (BGS) and another in
potassium buffered saline. Both swabs were refrigerated
and transported in a cool box to the central laboratory by
motorcycle and plated on the same day they were
obtained.
The specimens in BGS were plated on MacConkey agar
and Salmonella-Shigella agar. Biochemical reactions of col-
onies were evaluated in Kligler's iron agar and motility
indole ornithine medium. Colonies were serologically
confirmed by slide agglutination with appropriate group-
specific polyvalent antiserum, followed by type-specific
monovalent antisera. Standardized, commercial antisera
(Denka Seiken Co., Ltd. 3-4-2, Nihonbashi, Kayaba-Cho,
Chuo-Ku, Tokyo 103-0025, Japan) were used for identifi-
cation. In cases where no agglutination occurred with live
bacteria, the test was repeated with boiled suspensions of
bacteria.
For isolation of Vibrios, one rectal swab was placed in
Cary-Blair transport medium, kept at room temperature,
and transported to the central laboratory by motorcycle
and plated on the same day that were obtained. From the
Flow of diarrhoea patients Figure 1
Flow of diarrhoea patients.
16,872 cases presented to a participating health care provider with loose bowel movement and consented
to take part in the study
16,225 / 16,872 (96%) cases with a case report form completed and stool sample collected
647 / 16,872 (4%) did not fulfill the study
inclusion criteria*
1,691 Shigella and Vibrio isolates**
1,203 Shigella isolates 488 Vibrio isolates
866 (72%)
S. flexneri
277 (23%)
S. sonnei
21 (2%)
S. dysenteriae
39 (3%)
S. boydii
154 (32%)
V. cholerae O1
195 (40%)
V. cholerae non-
O1
139 (28%)
V. para-
haemolyticus
* inclusion criteria: diarrhea and consent to participate in the study
** More than one organism was isolated from 38 patientsBMC Infectious Diseases 2005, 5:89 http://www.biomedcentral.com/1471-2334/5/89
Page 4 of 11
(page number not for citation purposes)
Cary-Blair media, the specimens were plated directly onto
thiosulfate citrate bile salt sucrose (TCBS) agar (Eiken
Chemical Company, Tokyo, Japan) and also plated onto
TCBS after enrichment in alkaline peptone water for 6 and
20 hours (pH 8.6, 37°C). After incubation overnight, sus-
pected colonies on the TCBS plates were tested biochemi-
cally and agglutinated with polyvalent, Ogawa, and Inaba
antisera (Difco Laboratories, Detroit, Michigan). Non-
agglutinating strains were tested with antiserum to V. chol-
erae O139 strain. Identification of Vibrio parahaemolyticus
was done according to standard methods [19].
Antimicrobial susceptibility testing of Shigella and V. chol-
erae isolates against ampicillin, trimethoprim-sulfameth-
oxazole, chloramphenicol, tetracycline, cefotaxime,
ceftriaxone, ciprofloxacin, and nalidixic acid was per-
formed using standard antibiotic discs (Becton, Dickin-
son and Co., Sparks, MD). Isolates were assessed as being
resistant, intermediate or susceptible according to stand-
ard cut-off zone sizes [20]. A control strain, Escherichia coli
ATCC 25922, was included in the test.
Data management and analysis
All case report forms were double entered into custom-
made data entry programs using FoxPro software (Micro-
soft, Redmond, WA). The data management programs
include error as well as consistency check programs. SAS
software (SAS Institute Inc., Cary, NC) was used for statis-
tical analyses. Because ascertainment of cases was passive,
we did not know how many of the people included in the
study stayed in the study area. We estimated person-years
at risk assuming the study population stayed in the study
area until the end of the study period. We used the age-
specific number of disease episodes in residents of the
study area as the numerator. Incidence was calculated
based on the population residing in the catchment area in
Incidence of diarrhoea by sex and age group, North Jakarta, August 2001 to July 2003 Figure 2
Incidence of diarrhoea by sex and age group, North Jakarta, August 2001 to July 2003.
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Seasonality of diarrhoea, shigellosis and Vibrio infections, North Jakarta a. Diarrhoea, b. Shigellosis, c. Vibrio infections Figure 3
Seasonality of diarrhoea, shigellosis and Vibrio infections, North Jakarta a. Diarrhoea, b. Shigellosis, c. Vibrio infections.
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2001 as the denominator. A test for trend (chi square) was
applied to assess the statistical significance of increasing
incidence rates of shigellosis with increasing age (after age
30 years). For nonparametric data, Wilcoxon rank sum
test was used for the comparison of two groups. Chi
square test was used for the analysis of binary data. Stu-
dent's t test or chi square test was used, as appropriate, to
compare clinical features of cases by etiologic organism.
Ethics
After the project's purpose was explained, patients, or in
the case of minors, their parent or guardian, gave verbal
consent prior to participation in the study. Participation
consisted of providing a stool specimen and the informa-
tion required to complete the case report forms. The study
was approved by the Ethics Committee of the Ministry of
Health, Indonesia; the Institutional Review Board,
National Institute of Health Research and Development,
Ministry of Health, Jakarta, Indonesia; the Institutional
Review Board, United States Naval Medical Research Unit
No 2; and from the Secretariat Committee on Research
Involving Human Subjects, World Health Organization,
Geneva, Switzerland.
Results
Diarrhoea
From August 2001 through July 2003, 16 872 patients
presented to one of the participating treatment centres
with loose bowel movements and agreed to take part in
the study (Figure 1). 647 (4%) who did not fulfil the study
criteria (consent and diarrhea) were excluded and 16 225
(96%) diarrhoea cases were analyzed. In all, 1 203 Shigella
and 488 Vibrio organisms were isolated from the stool
samples. More than one organism was isolated from 38
patients. We found an overall incidence of diarrhoea of 50
per 1 000 population per year. The highest diarrhoea inci-
dence was in infants less than 1 year of age at 759 cases/1
000/year (Figure 2). Sixty-eight percent (10 998/16 225)
Incidence of shigellosis by Shigella species and age group infected, North Jakarta, August 2001 through July 2003 Figure 4
Incidence of shigellosis by Shigella species and age group infected, North Jakarta, August 2001 through July 2003.
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of diarrhoea cases were in children less than 5 years of age
(incidence of 349/1 000/year). Diarrhea incidence was
significantly higher in boys under 5 years (387/1 000/
year) than girls under 5 years (309/1 000/year; p < 0.001).
In contrast the reported diarrhea incidence in females 5
years and older (21/1 000/year) was significantly higher
than in males 5 years or older (16/1 000/year; p < 0.001).
Diarrhoea cases had a clear seasonality. During the first
three months of the year (January, February, March)
1578/16225 (38%) of diarrhea episodes were captured
and during the remainig 9 months 10 026 (62%) of the
diarrhea episodes were captured (p < 0.001; Figure 3).
Shigellosis
We found an overall incidence of shigellosis of 4/1 000/
year. Shigellosis was most common among children and
the elderly (Figure 4), with the highest incidence at 32/1
000/year in those 1 to 2 years of age. Of the 1 203 Shigella
isolates, 866 (72%) were S. flexneri, 277 (23%) were S.
sonnei, 21 (2%) were S. dysenteriae (none of which were S.
dysenteriae type 1), and 39 (3%) were S. boydii (Figure 1).
Incidence by type of specie was 2.6/1 000/year for S.
flexneri, 0.8 for S. sonnei, 0.1 for S. dysenteriae, and 0.1 for
S. boydii. The most frequently encountered S. flexneri sero-
types were 2a and 3a, followed by 1b and 1c (Table 1).
Two percent of the S. flexneri isolates could not be typed
with commercially available antisera. We evaluated the
antimicrobial resistance pattern of the Shigella isolates by
species. In all, 73% to 95% of S. flexneri isolates were
resistant to ampicillin, trimethoprim-sulfamethoxazole,
chloramphenicol, and tetracycline. None showed resist-
ance to ciprofloxacin and only a single isolate (of S.
flexneri) was not susceptible to ceftriaxone and nalidixic
acid. Significantly more shigellosis cases were detected
between February and April (418/1772; 36%) during the
rainy months compared to the remaining 9 months of the
year (754/1172; 64%; p < 0.001; Figure 3).
Cholera and other vibriosis
We found an overall incidence of cholera of 0.5/1 000/
year. Cholera was most common in children (Figure 5),
with the highest incidence at 4/1 000/year in those less
than 1 year of age. Of the 154 V. cholerae O1 isolates, 89
(58%) were of the El Tor Ogawa serotype and 65 (42%)
were El Tor Inaba. V. cholerae O139 was not isolated dur-
ing the two-year study period. The majority of isolates
(>90%) remain susceptible to the first-line antimicrobial
agents, trimethoprim-sulfamethoxazole and tetracycline
as well as nalidixic acid, ciprofloxacin and chlorampheni-
col. Cholera peaked in December. Significantly more
cases were detected between December and March (162/
443; 37%) during the cooler months compared to the
remaining 9 months of the year (281/443; 37%; p <
0.001; Figure 3).
During the surveillance, other Vibrio organisms were also
detected. The incidence of diarrhoea due to V. cholerae
non-O1 was 0.5/1 000/year and that due to V. parahaemo-
lyticus was 0.4/1 000/year. V. cholerae non-O1 diarrhoea
was most common among children and the elderly,
whereas the incidence of V. parahaemolyticus diarrhoea
gradually increased with age (Figure 5). Seasonality was
not clear for diarrhoea associated with V. cholerae non-O1
and V. parahaemolyticus (Figure 3). Initially, V. parahaemo-
lyticus infections were detected sporadically but increased
from July 2002 onwards.
Clinical features and management
We assessed clinical features and management of the diar-
rhoea cases and separately, those from whom Shigella and
Vibrio strains were isolated, excluding the 38 cases from
whom more than one organism was isolated (Table 4).
The mean and median ages of cases with diarrhoea due to
V. parahaemolyticus were significantly higher than those of
cases caused by other Vibrio or Shigella species (p < 0.001).
Only 10 to 25% of shigellosis cases, depending on the
specie, reported blood in the stool. Nearly all patients
(range 90 to 100%) were prescribed antibiotics. Ten per-
cent of patients with cholera were severely dehydrated,
34% were intravenously rehydrated, and 22% were
referred for hospital admission. Compared to cholera
cases, all other diarrhoea cases were less likely to have
severe dehydration (P value < 0.001), rehydrated with
intravenous fluids (P value < 0.001), or be hospitalized (P
value = 0.001).
Table 1: Shigella flexneri serotypes detected in North Jakarta, 
August 2001 to July 2003
Serotypes Number (%)
1a 63 7
1b 105 12
1c 103 12
2a 297 34
2b 5 1
3a 142 16
3b 10 1
41 2 1
4a 53 6
4b 1 <1
4X 11 1
5a 2 <1
63 8 4
X2 < 1
Y5 1
Non-typeable 17 2
Total 866 100BMC Infectious Diseases 2005, 5:89 http://www.biomedcentral.com/1471-2334/5/89
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Discussion
This is the first community-based surveillance of diar-
rhoea in Jakarta and our findings underscore its public
health significance especially amongst children less than
60 months of age. By utilizing passive surveillance, that is
detecting patients coming to health centres for treatment,
we found an annual incidence of diarrhoea requiring
medical attention of 349 per 1 000 children and 759 per
1000 infants.
The study was designed in preparation of vaccine trials try-
ing to find an appropriate population for the evaluation
of vaccine candidates. The residents of two kecamatans,
Tanjung Priok and Koja were selected as study population
for the study based on their accessibility and the relative
high incidence of the target diseases. We have found that
in this population only 39% of diarrhea episodes overall
would trigger a visit to a health care centre. Taking into
account the lack of sensitivity of the classic culture meth-
ods used in the study it is reasonable to assume that the
true disease incidence could be several fold higher than
our estimates. Our study population is likely to be
representative of the less affluent segment of the popula-
tion of Jakarta which depends on the public health care
system. However the study population was not chosen
because it is representative for the population of Jakarta.
More affluent households in North Jakarta may prefer to
make use of the private sector and were not captured by
the study. The incidence of the target diseases estimated
by our study may differ in the more affluent population.
The incidence of shigellosis was highest in children
between 1 and 2 years of age, consistent with previous
data indicating that maternal antibodies and breast-feed-
ing may protect newborns and infants [21-23]. We found
increasing rates of shigellosis in those 70 years of age and
older, which could be related to waning of immunity. S.
flexneri was the most frequently detected Shigella species
Incidence of Vibrio cholerae and Vibrio parahaemolyticus by age group, North Jakarta, August 2001 through July 2003 Figure 5
Incidence of Vibrio cholerae and Vibrio parahaemolyticus by age group, North Jakarta, August 2001 through July 2003.
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and four S. flexneri serotypes (2a, 3a, 1b, 1c) made up 74%
of the S. flexneri isolates. This finding is consistent with
those from a previous report that suggested that the most
frequent S. flexneri serotypes are 2a, 1b, and 3b [24].
The highest number of diarrhea cases was detected each
year during the rainy season between January and April
when North Jakarta is particularly flood prone. The
number of detected cholera cases peaked each year in Jan-
uary. Relatively few V. parahaemolyticus strains were
detected during the first year of the study which became
the dominant Vibrio species towards the end of the study.
The increase in V. parahaemolyticus detection may well
have been related to the pandemic spread of the V. para-
haemolyticus  serovar O3:K6 though the serovar of the
strains has yet to be determined. The detection of all Shig-
ella strains coincided with the rainy season (January
through April) and had a distinct peak in April of the first
year of surveillance.
The greatest burden of cholera was in children during the
first year of life. Previously, cholera was believed to occur
infrequently below 2 years of age [25] but more recent
studies have found cholera to be a significant problem in
young children [26,27]. We found significant numbers of
diarrhoea cases due to other Vibrio species. These diar-
rhoea episodes were more likely to occur in adults than in
children as previously reported [8,28]. V. parahaemolyticus
infections are transmitted through unsafe foods, such as
raw or undercooked seafood, which are more likely to be
consumed by adults [8]. V. cholerae non-O1 and V.
parahaemolyticus were associated with milder illness than
V. cholerae O1.
The large majority of study patients received rehydration
fluids (mostly orally) in accord with international guide-
lines. Only 4% of diarrhoea patients reported taking anti-
biotics prior to presentation which is surprising
considering the ubiquitous presence of drug vendors in
the study area. Resistance of Shigella to quinolones is not
yet a major problem in the area but resistance to the more
commonly used first-line antimicrobials is disturbing.
Ampicillin, tetracycline, chloramphenicol, and trimetho-
prim-sulfamethoxazole are of little use for treatment of S.
flexneri in the study area. Antimicrobial resistance of V.
cholerae is not yet a major problem in Jakarta. However
Table 2: Clinical features and management of diarrhoea cases, by organism isolated (excluding 38 cases with mixed infections)
Diarrhoea 
cases 
N = 16,187
Shigella Vibrio
flexneri
N = 844
sonnei
 N = 269
dysenteriae
 N = 21
boydii
 N = 38
cholerae O1
 N = 143
cholerae non-O1
 N = 171
parahaemolyticus
 N = 129
Mean (median) age 
in years
11 (2) 19 (11) 7 (2) 22 (8) 23 (20) 15 (7) 14 (3) 33 (32)
Number (%) female 7,643 (47) 479 (57) 135 (50) 7 (33) 25 (66) 78 (55) 84 (49) 75 (58)
Number (%) with 
liquid stool
15,543 (96) 787 (93) 250 (93) 18 (86) 35 (92) 140 (98) 166 (97) 129 (100)
Number (%) with 
bloody stool
1,174 (7) 213 (25) 42 (16) 2 (10) 8 (21) 6 (4) 11 (6) 5 (4)
Number (%) with 
vomiting
7,053 (44) 231 (27) 71 (26) 7 (33) 4 (11) 75 (53) 72 (42) 77 (60)
Number (%) who 
had taken antibiotics
607 (4) 42 (6) 8 (3) 0 0 5 (4) 3 (2) 1 (1)
Number (%) with 
severe dehydration
168 (1) 4 (1) 0 0 0 14 (10) 5 (3) 0
Number (%) with 
fever
5,164 (33) 279 (34) 89 (33) 8 (38) 7 (19) 24 (17) 52 (31) 25 (19)
Number (%) orally 
rehydrated
11,597 (72) 547 (65) 194 (72) 14 (67) 26 (68) 108 (76) 126 (74) 91 (71)
Number (%) 
intravenously 
rehydrated
2,338 (14) 77 (9) 12 (4) 2 (10) 2 (5) 49 (34) 23 (14) 33 (26)
Number (%) 
prescribed 
antibiotics
14,800 (97) 803 (98) 253 (98) 20 (100) 29 (100) 127 (98) 153 (90) 120 (93)
Number (%) 
referred to hospital
2,044 (13) 57 (7) 13 (5) 0 2 (5) 31 (22) 20 (12) 20 (16)BMC Infectious Diseases 2005, 5:89 http://www.biomedcentral.com/1471-2334/5/89
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the surprisingly high percentage of diarrhea patients who
were prescribed antibiotics is worrying as the drug pres-
sure is likely to select resistant strains and is unlikely to
benefit many the patients.
Conclusion
In conclusion, diarrhoea causes a heavy public health bur-
den in Jakarta. The impact of shigellosis is exacerbated by
the threat of antimicrobial resistance, whereas that of
cholera is aggravated by its severe manifestations.
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